TP53 and colorectal carcinoma: In agreement, TAM treatment in Mif+l+;TP53Q/Q tumors showed no decreased tumor area compared to oil treatment (Supplementary Fig. S4C) and thus, Tamoxifen have not gained unspecific effects in none of the TP53-engineered CRC mouse models.